tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MCRB is currently covered by 7 analysts with an average price target of $8.62. This is a potential upside of $7.79 (938.55%) from yesterday's end of day stock price of $0.83.
Seres Therapeutics's activity chart (see below) currently has 37 price targets and 38 ratings on display. The stock rating distribution of MCRB is 92.86% BUY and 7.14% SELL.
Analysts average stock forecasts to be materialized ratio is 34.66% with an average time for these price targets to be met of 89.78 days.
Highest price target for MCRB is $12, Lowest price target is $1.25, average price target is $8.62.
Most recent stock forecast was given by CHRIS SHIBUTANI from GOLDMAN SACHS on 03-Nov-2023. First documented stock forecast 22-Oct-2015.
Currently out of the existing stock ratings of MCRB, 13 are a BUY (92.86%), 1 are a SELL (7.14%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1.25
$0.11 (9.65%)
24
5 months 26 days ago
3/4 (75%)
$-0.05 (-3.85%)
130
Buy
12
$10.86 (952.63%)
13
10 months 3 days ago
3/9 (33.33%)
$6.6 (122.22%)
355
Buy
10
$8.86 (777.19%)
12
1 years 1 days ago
0/4 (0%)
$5.12 (104.92%)
Buy
12
$10.86 (952.63%)
29
1 years 2 days ago
3/4 (75%)
$6.68 (125.56%)
38
Buy
15
$13.86 (1215.79%)
11
1 years 1 months 8 days ago
0/6 (0%)
$8.91 (146.31%)
What is MCRB (Seres Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MCRB (Seres Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MCRB (Seres Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MCRB (Seres Therapeutics)?
Which analyst is the currently most bullish on MCRB (Seres Therapeutics)?
Which analyst is the currently most reserved on MCRB (Seres Therapeutics)?
